Novo CEO signals M&A opportunities to strengthen drug pipeline
Source:
cnbc
September 22, 2026 · 02:00
From the publisher
Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market.
The original article opens on the publisher's website.
More from General
View topic →A new skyline of data centres is rising from the rolling plains of rural China
bbcTechnology
Sep 22, 2026 · 15:04
Billy Bush Joins Fox News a Decade After ‘Access Hollywood’ Tape Scandal
nytimes
Sep 22, 2026 · 14:56
Snorkel AI triples valuation to $3.5B as demand for AI training data booms
techcrunch
Sep 22, 2026 · 14:56
Trump Officials Eject 750,000 From Obamacare Markets, Claiming Fraud
nytimes
Sep 22, 2026 · 14:55
Questions remain after grand jury declines indictment in Nolan Wells' death
nprNews
Sep 22, 2026 · 14:47